F. Abegaz, F. Van Lishout, J. M. M. John, K. Chiachoompu, A. Bhardwaj, D. Duroux, E. S. Gusareva, Z. Wei, H. Hakonarson, and K. Van Steen. "Performance of model-based multifactor dimensionality reduction methods for epistasis detection by controlling population structure." BioData Mining 14, no. 1 (2021): 1--20.
S. Graff, D. Zanella, P.-H. Stefanuto, M. HENKET, V. PAULUS, F. GUISSARD, C. MOERMANS, K. Van Steen, R. Louis, and F. Schleich. "Are Volatile Organic Compounds Able to Identify Airflow Decline in Asthma?" Journal of Asthma and Allergy 14 (2021): 67-70.
M. Hall, J. Wallace, A. Lucas, et al, K. Van Steen, J. Moore, and M. Ritchie. "Novel EDGE encoding method enhances ability to identify genetic interactions." PLoS Genetics 17, no. 6 (2021): 1009534.
M. Zanin, N. N. A. A. Aitya, J. Basilio, J. Baumbach, A. Benis, C. C. K. Behera, M. Bucholc et al. "An Early Stage Researcher's Primer on Systems Medicine Terminology." Network and Systems Medicine 4, no. 1 (2021).
K. Chaichoompu, F. Abegaz, B. Cavadas, V. Fernandes, B. Muller-Myhsok, L. Pereira, and K. Van Steen. "A different view on fine-scale population structure in Western African populations." Human Genetics 139, no. 1 (2020): 45-59.
F. Cottone, G. S. Collins, A. Anota, K. Sommer, J. M. Giesinger, J. M. Kieffer, N. K. Aaronson, K. Van Steen, E. Charton, and F. Castagnetti. "Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapies." Journal of Clinical Epidemiology (2020).
I. Detrez, D. Thomas, K. Van Steen, V. Ballet, M. Peeters, M. F. Hoylaerts, G. Van Assche, S. Vermeire, M. Ferrante, and A. Gils. "Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients." Journal of clinical gastroenterology (2020).
J. Li, T. Gonzalez, J. D. White, K. Indencleef, H. Hoskens, A. O. Castrillon, N. Nauwelaers et al. "Robust Genome-Wide Ancestry Inference for Heterogeneous Datasets and Ancestry Facial Imaging based on the 1000 Genomes Project." Scientific Reports (2020).
E. Stalidzans, M. Zanin, P. Tieri, F. Castiglione, A. Polster, S. Scheiner, J. Pahle et al. "Mechanistic Modeling and Multiscale Applications for Precision Medicine: Theory and Practice." Network and Systems Medicine (2020).
S. Watterson, B. Comte, J. Baumbach, A. Benis, J. Basilio, N. Debeljak, A. Flobak et al. "Network and systems medicine: Position paper of the European Collaboration on Science and Technology action on Open Multiscale Systems Medicine." Network and Systems Medicine (2020).
M. Joiret, J. Mahachie John, E. Gusareva, and K. Van Steen. "Confounding of linkage disequilibrium patterns in large scale DNA based gene-gene interaction studies." BioData Mining 12, no. 11 (June 10, 2019): 1-23.
F. Cottone, N. Deliu, G. Collins, A. Anota, F. Bonnetain, K. Van Steen, D. Cella, and F. Efficace. "Modelling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncology." Quality of Life Research (January 18, 2019).
F. Abegaz, K. Chaichoompu, E. Genin, D. W. Fardo, I. R. König, J. M. Mahachie John, and K. Van Steen. "Principals about principal components in statistical genetics." Briefings in Bioinformatics (2019).
F. Abegaz, F. Van Lishout, J. M. Mahachie John, K. Chiachoompu, A. Bhardwaj, E. S. Gusareva, Z. Wei, H. Hakonarson, K. Van Steen, and I. B. D. G. C. International. "Epistasis Detection in Genome-Wide Screening for Complex Human Diseases in Structured Populations." Systems Medicine 2, no. 1 (2019): 19-27.
K. Chaichoompu, F. Abegaz Yazew, S. Tongsima, P. J. Shaw, A. Sakuntabhai, L. Pereira, and K. Van Steen. "IPCAPS: an R package for iterative pruning to capture population structure." Source Code for Biology and Medicine 14 (2019).
A. Romagnoni, S. Jegou, K. Van Steen, G. Wainrib, and J.-P. Hugot. "Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data." Scientific Reports 9, no. 1 (2019): 10351.
F. SCHLEICH, D. Zanella, P.-H. Stefanuto, J. Dallinga, M. HENKET, E. F. M. Wouters, K. Van Steen, F. Van Schooten, J.-F. Focant, and R. Louis. "Exhaled Volatile Organic Compounds Are Able to Discriminate Between Neutrophilic and Eosinophilic Asthma." AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 200, no. 4 (2019): 444-453.
K. Van Steen and J. Moore. "How to increase our belief in discovered statistical interactions via large-scale association studies?" Human Genetics (2019).
J. Zhang, Z. Wei, C. J. Cardinale, E. Gusareva, K. Van Steen, P. Sleiman, H. Hakonarson, and I. I. B. D. G. Consortium. "Multiple Epistasis Interactions Within MHC Are Associated With Ulcerative Colitis." FRONTIERS IN GENETICS 10 (2019).
M. H. T. Wang, H. J. Cordell, and K. Van Steen. "Statistical methods for genome-wide association studies." Seminars in Cancer Biology (May 1, 2018).
E. Dreesen, T. Van Stappen, V. Ballet, M. Peeters, G. Compernolle, S. Tops, K. Van Steen et al. "Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response." Alimentary Pharmacology and Therapeutics 47, no. 3 (2018): 346-355.
E. S. Gusareva, J.-C. Twizere, K. Sleegers, P. Dourlen, J. F. Abisambra, S. Meier, R. Cloyd et al. "Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease." Neurobiology of Aging 72 (2018): 1883-18812.
M. Ritchie and K. Van Steen. "The search for gene-gene interactions in genome-wide association studies: challenges in abundance of methods, practical considerations, and biological interpretation." Annals of Translational Medicine 6, no. 8 (2018): 157.
K. Bessonov, F. Gadaleta, and K. Van Steen. "Integration of Gene Expression and Methylation to unravel Biological Networks in Glioblastoma Patients." Genetic Epidemiology (2017).
R. Bisschops, T. Bessissow, E. Dekker, J. E. East, A. Para-Blanco, K. Ragunath, P. Bhandari et al. "Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitis." Gastrointestinal Endoscopy 86, no. 6 (2017): 1100-11061.
I. Detrez, K. Van Steen, S. Segaert, and A. Gils. "The association between etanercept serum concentration and psoriasis severity is highly age-dependent." Clinical Science 131, no. 11 (2017): 1179-1189.
R. J. J. Elands, C. C. J. M. Simons, M. Riemenschneider, A. Isaacs, L. J. Schouten, B. A. Verhage, K. Van Steen et al. "A systematic SNP selection approach to identify mechanisms underlying disease aetiology: Linking height to post-menopausal breast and colorectal cancer risk." Scientific Reports 7 (2017).
D. P. Hibar, H. H. H. Adams, N. Jahanshad, G. Chauhan, J. L. Stein, E. Hofer, M. E. Renteria et al. "Novel genetic loci associated with hippocampal volume." Nature Communications 8 (2017): 13624.
K. Machiels, J. Sabino, L. Vandermosten, M. Joossens, I. Arijs, M. de Bruyn, V. Eeckhaut et al. "Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC." Gut 66, no. 1 (2017): 79-88.
S. Pineda, K. Van Steen, and N. Malats. "Integrative eQTL analysis of tumor and host omics data in individuals with bladder cancer." Genetic Epidemiology 41, no. 6 (2017): 567-573.
K. Bessonov and K. Van Steen. "Practical aspects of gene regulatory inference via conditional inference forests from expression data." Genetic Epidemiology (December 2016).
H. H. H. Adams, D. P. Hibar, V. Chouraki, J. L. Stein, P. A. Nyquist, M. E. Renteria, S. Trompet et al. "Novel genetic loci underlying human intracranial volume identified through genome-wide association." Nature Neuroscience 19, no. 12 (2016): 1569-1582.
D. Gola, J. Mahachie John, K. Van Steen, and I. R. Konig. "A roadmap to multifactor dimensionality reduction methods." Briefings in Bioinformatics 17, no. 2 (2016): 293-308.
E. Lopez de Maturana, S. Pineda, A. Brand, K. Van Steen, and N. Malats. "Toward the integration of omics data in epidemiological studies: still a "long and winding road"." Genetic Epidemiology 40 (2016): 558-569.
S. Pineda San Juan, F. X. Real, M. Kogevinas, A. Carrato, S. J. Chanock, N. Malats, and K. Van Steen. "Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer." PLoS Genetics (December 8, 2015).
F. Van Lishout, F. Gadaleta, J. H. Moore, L. Wehenkel, and K. Van Steen. "gammaMAXT: a fast multiple-testing correction algorithm." BioData Mining 8, no. 36 (November 20, 2015).
R. Fouladi, K. Bessonov, F. Van Lishout, and K. Van Steen. "Model-Based Multifactor Dimensionality Reduction for Rare Variant Association Analysis." Human Heredity 79 (July 2015): 157-167.
K. Bessonov, E. Gusareva, and K. Van Steen. "A cautionary note on the impact of protocol changes for Genome-Wide Association SNP x SNP Interaction studies: an example on ankylosing spondylitis." Human Genetics (April 27, 2015).
P. Goyette, G. Boucher, D. Mallon, E. Ellinghaus, L. Jostins, H. Huang, S. Ripke et al. "High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis." Nature Genetics 47, no. 2 (January 5, 2015): 172-9.
L. Bollen, N. Vande Casteele, M. Peeters, K. Bessonov, K. Van Steen, P. Rutgeerts, M. Ferrante, M. F. Hoylaerts, S. Vermeire, and A. Gils. "Short-term Effect of Infliximab Is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease: A Prospective Study." Inflammatory Bowel Diseases 21, no. 3 (2015): 570-8.
I. Cleynen, P. Konings, C. Robberecht, D. Laukens, L. Amininejad, E. Théâtre, K. Machiels et al. "Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease." Inflammatory Bowel Diseases (2015).
D. Drobne, P. Bossuyt, C. Breynaert, T. Cattaert, N. Vande Casteele, G. Compernolle, M. Jurgens et al. "Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn's Disease." Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 13, no. 3 (2015): 514-5214.
L. Grange, J.-F. Bureau, I. Nikolayeva, R. Paul, K. Van Steen, B. Schwikowski, and A. Sakuntabhai. "Filter-free exhaustive odds ratio-based genome-wide interaction approach pinpoints evidence for interaction in the HLA region in psoriasis." BMC Genetics 16, no. 1 (2015): 11.
D. P. Hibar, J. L. Stein, M. E. Renteria, A. Arias-Vasquez, S. Desrivieres, N. Jahanshad, R. Toro et al. "Common genetic variants influence human subcortical brain structures." Nature 520, no. 7546 (2015): 224-9.
Z. Li, S. Vermeire, D. Bullens, M. Ferrante, K. Van Steen, M. Noman, X. Bossuyt, P. Rutgeerts, J. L. Ceuppens, and G. Van Assche. "Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases." Inflammatory Bowel Diseases 21, no. 12 (2015): 2787-96.
Z. Li, S. Vermeire, D. Bullens, M. Ferrante, K. Van Steen, M. Noman, P. Rutgeerts, J. L. Ceuppens, and G. Van Assche. "Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy." Inflammatory Bowel Diseases 21, no. 10 (2015): 2418-28.
K. Machiels, J. Sabino, L. Vandermosten, M. Joossens, I. Arijs, M. de Bruyn, V. Eeckhaut et al. "Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC." Gut (2015).
T. Park, K. Van Steen, X.-Y. Lou, and M. Xiong. "Statistical Analysis of High-Dimensional Genetic Data in Complex Traits." BioMed Research International 2015 (2015): 564273.
S. Pineda San Juan, P. Gómez-Rubio, P. Antoni, K. Bessonov, M. Márquez, M. Kogevinas, F. Real, K. Van Steen, and N. Malats. "Framework for the integration of genomics, epigenomics, and transcriptomics in complex diseases." Human Heredity (2015).
S. Pineda, P. Gomez-Rubio, A. Picornell, K. Bessonov, M. Marquez, M. Kogevinas, F. X. Real, K. Van Steen, and N. Malats. "Framework for the Integration of Genomics, Epigenomics and Transcriptomics in Complex Diseases." Human Heredity 79, no. 3-4 (2015): 124-36.
K. Van Steen and N. Malats. "Perspectives on Data Integration in Human Complex Disease Analysis." In Big Data Analytics in Bioinformatics and Healthcare. IGI-global, 2015. 39.
N. Vande Casteele, M. Ferrante, G. Van Assche, V. Ballet, G. Compernolle, K. Van Steen, S. Simoens, P. Rutgeerts, A. Gils, and S. Vermeire. "Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease." Gastroenterology 148, no. 7 (2015): 1320-93.
E. Gusareva and K. Van Steen. "Practical aspects of genome-wide association interaction analysis." Human Genetics 133, no. 11 (November 2014): 1343-58.
E. Gusareva, M. M. Carrasquillo, C. Bellenguez, E. Cuyvers, S. Colon, N. R. Graff-Radford, R. C. Petersen et al. "Genome-Wide Association Interaction Analysis for Alzheimer’s Disease." Neurobiology of Aging (May 28, 2014).
F. Beigel, A. Steinborn, F. Schnitzler, C. Tillack, S. Breiteneicher, J. M. John, K. Van Steen et al. "Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies." Pharmacoepidemiology and Drug Safety 23, no. 7 (2014): 735-44.
L. Bollen, M. Peetermans, M. Peeters, K. Van Steen, M. F. Hoylaerts, P. J. Declerck, P. Verhamme, and A. Gils. "Active PAI-1 as marker for venous thromboembolism: case-control study using a comprehensive panel of PAI-1 and TAFI assays." Thrombosis Research 134, no. 5 (2014): 1097-102.
A.-L. Boulesteix, S. Janitza, A. Hapfelmeier, K. Van Steen, and C. Strobl. "Letter to the Editor: On the term 'interaction' and related phrases in the literature on Random Forests." Briefings in Bioinformatics (2014).
M. de Bruyn, I. Arijs, W.-J. Wollants, K. Machiels, K. Van Steen, G. Van Assche, M. Ferrante, P. Rutgeerts, S. Vermeire, and G. Opdenakker. "Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis." Inflammatory Bowel Diseases 20, no. 7 (2014): 1198-207.
E. De Greef, B. Maus, F. Smets, S. Van Biervliet, J. M. M. John, K. Van Steen, and G. Veereman. "Diagnosing and treating pediatric Crohn's disease patients: is there a difference between adult and pediatric gastroenterologist's practices ? Results of the BELCRO cohort." Acta Gastro-Enterologica Belgica 77, no. 1 (2014): 25-9.
F. Gadaleta and K. Van Steen. "Discovering main genetic interactions with LABNet LAsso-based network inference." PLoS ONE 9, no. 11 (2014): 110451.
T. E. Galesloot, K. Van Steen, L. A. L. M. Kiemeney, L. L. Janss, and S. H. Vermeulen. "A comparison of multivariate genome-wide association methods." PLoS ONE 9, no. 4 (2014): 95923.
O. E. Savenije, J. Mahachie John, R. Granell, M. Kerkhof, F. N. Dijk, J. C. de Jongste, H. A. Smit et al. "Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood." Journal of Allergy and Clinical Immunology (2014).
P. M. Thompson, J. L. Stein, S. E. Medland, D. P. Hibar, A. A. Vasquez, M. E. Renteria, R. Toro et al. "The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data." Brain Imaging and Behavior 8, no. 2 (2014): 153-82.
F. Van Lishout, J. Mahachie John, E. Gusareva, V. Urrea, I. Cleynen, E. Theatre, B. CHARLOTEAUX, M. L. Calle, L. Wehenkel, and K. Van Steen. "An efficient algorithm to perform multiple testing in epistasis screening." BMC Bioinformatics 14 (April 24, 2013): 138.
G. Veereman, J. Mahachie John, E. De Greef, F. Smets, S. Van Biervliet, and K. Van Steen. "Therapeutic Strategy and Patient Outcome during the First 2 Years of Pediatric Crohn’s Disease." Acta Gastro-Enterologica Belgica (February 2013).
C. Breynaert, T. Dresselaers, C. Perrier, I. Arijs, J. Cremer, L. Van Lommel, K. Van Steen et al. "Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease." PLoS ONE 8, no. 7 (2013): 68876.
I. Cleynen, E. Vazeille, M. Artieda, H. W. Verspaget, M. Szczypiorska, M.-A. Bringer, P. L. Lakatos et al. "Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease." Gut (2013).
E. De Greef, J. Mahachie John, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser et al. "Profile of pediatric Crohn's disease in Belgium." Journal of Crohn's and Colitis 7, no. 11 (2013): 588-98.
F. Haerynck, J. Mahachie John, K. Van Steen, P. Schelstraete, S. Van daele, B. Loeys, M. Van Thielen, I. De Canck, L. Nuytinck, and F. De Baets. "Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients." Human Immunology 74, no. 12 (2013): 1649-55.
E. Hoefkens, J. Mahachie John, K. Van Steen, K. Nys, G. Van Assche, P. Agostinis, P. Rutgeerts, S. Vermeire, and I. Cleynen. "Crohn’s disease susceptibility genes involved in microbial sensing, autophagy and endoplasmic reticulum (er) stress and their interaction." Autophagy (2013).
E. Hoefkens, K. Nys, J. M. John, K. Van Steen, I. Arijs, J. Van der Goten, G. Van Assche et al. "Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress." Autophagy 9, no. 12 (2013): 2046-55.
J. Mahachie John, E. Gusareva, F. Van Lishout, and K. Van Steen. "A robustness study to investigate the performance of parametric and non-parametric tests used in Model-Based Multifactor Dimensionality Reduction Epistasis Detection." BioData Mining (2013).
B. Maus, C. Jung, J. Mahachie John, J.-P. Hugot, E. Genin, and K. Van Steen. "Molecular reclassification of Crohn's disease: a cautionary note on population stratification." PLoS ONE 8, no. 10 (2013): 77720.
R. Milne, C. La Vecchia, K. Van Steen, S. Hahn, M. Buchholz, E. Costello, I. Esposito et al. "EU Pancreas: An Integrated European Platform for Pancreas Cancer Research - from Basic Science to Clinical and Public Health Interventions for a Rare Disease." Public Health Genomics 16, no. 6 (2013): 305-12.
S. Salvatore, A. Salvatoni, K. Van Steen, D. Ummarino, B. Hauser, and Y. Vandenplas. "Behind the (impedance) baseline in children." Diseases of the Esophagus (2013).
S. Salvatore, A. Salvatoni, M. Van Berkel, K. Van Steen, D. Unmarino, A. Ghanma, B. Hauser, and Y. Vandenplas. "Esophageal impedance baseline is age dependent." Journal of Pediatric Gastroenterology and Nutrition 57, no. 4 (2013): 506-13.
Z. Wei, W. Wang, J. Bradfield, J. Li, C. Cardinale, E. Frackelton, C. Kim et al. "Large Sample Size, Wide Variant Spectrum, and Advanced Machine-Learning Technique Boost Risk Prediction for Inflammatory Bowel Disease." American Journal of Human Genetics (2013).
T. Bessissow, B. Lemmens, M. Ferrante, R. Bisschops, K. Van Steen, K. Geboes, G. Van Assche, S. Vermeire, P. Rutgeerts, and G. De Hertogh. "Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing." American Journal of Gastroenterology 11, no. 107 (November 2012): 1684-92.
E. De Greef, J. Mahachie John, I. Hoffman, F. Smets, S. Van Biervliet, B. Hauser, I. Paquot et al. "Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn's disease patients (BELCRO)." Gastroenterology (May 2012).
I. Cleynen, M. Artieda, H. Verspaget, P. Lakatos, F. Seibold, T. Ahmad, R. Weersma et al. "Multiple functional variants at the 3p21 locus contribute to ulcerative colitis: Results from a European consortium." Journal of Crohn's and Colitis (February 2012).
I. Cleynen, E. Vazeille, M. Artieda, M. Szczypiorska, M.-A. Bringer, W. Verspaget, P. Lakatos et al. "Genetic and functional evidence for a role of CYLD in Crohn’s Disease: results from a European consortium." Journal of Crohn's and Colitis (February 2012).
J. Mahachie John, T. Cattaert, F. Van Lishout, E. Gusareva, and K. Van Steen. "Lower-Order Effects Adjustment in Quantitative Traits Model-Based Multifactor Dimensionality Reduction." PLoS ONE (January 5, 2012).
H. Aschard, S. Lutz, B. Maus, E. J. Duell, T. E. Fingerlin, N. Chatterjee, P. Kraft, and K. Van Steen. "Challenges and opportunities in genome-wide environmental interaction (GWEI) studies." Human Genetics 131 (2012): 1591-1613.
C. Bachert, K. Van Steen, N. Zhang, G. Holtappels, T. Cattaert, B. Maus, R. Buhl et al. "Specific IgE against Staphylococcus aureus enterotoxins: An independent risk factor for asthma." Journal of Allergy and Clinical Immunology 130, no. 2 (2012): 376-3818.
E. De Greef, I. Hoffman, G. D'haens, S. Van Biervliet, F. Smets, M. Scaillon, O. De Wit et al. "Safety And Cost Of Infliximab For The Treatment Of Belgian Pediatric Patients With Crohn’s Disease." Journal of Crohn's and Colitis (2012).
E. De Greef, I. Hoffman, G. D'Haens, S. Van Biervliet, F. Smets, M. Scaillon, O. Dewit et al. "Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease." Acta Gastro-Enterologica Belgica 75, no. 4 (2012): 425-31.
E. De Greef, J. Mahachie John, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser et al. "Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn’s disease patients (BELCRO)." Acta Gastro-Enterologica Belgica (2012).
L. De Lobel, L. Thijs, T. Kouznetsova, J. Staessens, and K. Van Steen. "A family-based association test to detect gene-gene interactions in the presence of linkage." European Journal of Human Genetics (2012).
F. Haerynck, K. Van Steen, T. Cattaert, B. Loeys, S. Van Daele, P. Schelstraete, K. Claes et al. "Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients." Human Immunology (2012).
K. Lødrup Carlsen, S. Roll, K.-H. Carlsen, P. Mowinckel, A. Wijga, B. Brunekreef, M. Torrent et al. "Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts." PLoS ONE (2012).
B. Maus, E. Génin, J. Mahachie John, and K. Van Steen. "Clustering of Crohn’s disease patients: Identification of sub-phenotypes and population stratification." Genetic Epidemiology 36, no. 7 (2012): 729.
K. Op De Beeck, L. Maes, K. Van den Bergh, R. Derua, E. Waelkens, K. Van Steen, P. Vermeersch et al. "Heterogeneous nuclear ribonucleoproteins as targets of autoantibodies in systemic rheumatic diseases." Arthritis and Rheumatism 64, no. 1 (2012): 213-221.
J. L. Stein, S. E. Medland, A. A. Vasquez, D. P. Hibar, R. E. Senstad, A. Winkler, R. Toro et al. "Identification of common variants associated with human hippocampal and intracranial volumes." Nature Genetics 44, no. 5 (2012): 552-61.
M. Vieira, N. Miyague, K. Van Steen, S. Salvatore, and Y. Vandenplas. "Effects of domperidone on QTc interval in infants." Acta Paediatrica 101, no. 5 (2012): 494-496.
J. Mahachie John, T. Cattaert, L. De Lobel, F. Van Lishout, A. Empain, and K. Van Steen. "Comparison of genetic association strategies in the presence of rare alleles." BMC Proceedings (November 29, 2011).
T. Ochsenkühn, A. Steinborn, F. Beigel, J. Mahachie John, K. Van Steen, S. Schnitzler, C. Tillack et al. "Rate of Malignancies and Infections in a Large Single Center Cohort of IBD Patients Treated With Thiopurines and Anti-TNF-Antibodies." Gut (October 2011).
T. Ochsenkühn, A. Steinborn, F. Beigel, S. Breiteneicher, J. Mahachie John, K. Van Steen, F. Schnitzler et al. "Rate of Malignancies and Infections in a Large Single Center Cohort of IBD Patients Treated With Thiopurines and Anti-TNF-Antibodies." American Journal of Gastroenterology (May 2011).
I. Arijs, L. Van Lommel, G. De Hertogh, K. Machiels, K. Lemaire, K. Van Steen, G. Van Assche, S. Vermeire, F. Schuit, and P. Rutgeerts. "Mucosal gene expression profiling differentiates early from late ileal Crohn's disease." Acta Gastro-Enterologica Belgica (2011).
I. Arijs, G. De Hertogh, K. Machiels, K. Van Steen, K. Lemaire, A. Schraenen, L. Van Lommel et al. "Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment." American Journal of Gastroenterology 106, no. 4 (2011): 748-61.
C. Breynaert, F. Ferrante, H. Fidder, K. Van Steen, M. Noman, V. Ballet, S. Vermeire, P. Rutgeerts, and G. Van Assche. "Tolerability of shortened infliximab infusion times in patients with inflammatory bowel disease: a single center cohort study." Acta Gastro-Enterologica Belgica (2011).
C. Breynaert, M. Ferrante, H. Fidder, K. Van Steen, M. Noman, V. Ballet, S. Vermeire, P. Rutgeerts, and G. Van Assche. "Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study." American Journal of Gastroenterology 106, no. 4 (2011): 778-85.
T. Cattaert, L. M. Calle, S. T. Dudek, J. Mahachie John, F. Van Lishout, V. Urrea, M. D. Ritchie, and K. Van Steen. "Model-Based Multifactor Dimensionality Reduction for detecting epistasis in case-control data in the presence of noise." Annals of Human Genetics 75, no. 1 (2011): 78-89.
I. Cleynen, M. Artieda, M. Szczyoiorska, W. Verspaget, L. Lakatos, F. Seibold, T. Ahmad et al. "The protease genes CYLD and USP40 are associated with Crohn's disease: results from a European Consortium." Gastroenterology 140, no. 5 (2011): 269.
I. Cleynen, W. Van Moerkercke, N. Vande Casteele, V. Ballet, M. Juergens, C. Breynaert, D. Drobne et al. "Anti-TNF induced skin manifestations in IBD patients: characterization and search for predisposing factors." Acta Gastro-Enterologica Belgica 74 (2011).
E. De Greef, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser, I. Paquot et al. "Profile of Belgian Pediatric Crohn's Disease Patients: Associations between variables at diagnosis." Acta Gastro-Enterologica Belgica 74 (2011): 07.
E. De Greef, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser, I. Paquot et al. "Profile of Belgian Pediatric Crohn's Disease Patients: Associations between variables at diagnosis." Journal of Crohn's and Colitis 5, no. 1 (2011): 156.
E. De Greef, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser, I. Paquot et al. "Profile of Belgian Pediatric Crohn's Disease Patients: Associations between variables at diagnosis." Gastroenterology 140, no. 5 (2011): 787.
E. De Greef, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser, I. Paquot et al. "Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features." Gastroenterology 140, no. 5 (2011): 786.
E. De Greef, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser, I. Paquot et al. "Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features." Acta Gastro-Enterologica Belgica 74 (2011): 05.
E. De Greef, I. Hoffman, F. Smets, S. Van Biervliet, M. Scaillon, B. Hauser, I. Paquot et al. "Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features." Journal of Crohn's and Colitis 5, no. 1 (2011): 155.
D. Drobne, P. Bossuyt, C. Breynaert, N. Vande Casteele, G. Compernolle, M. Juergens, V. Ballet et al. "Long term evolution and impact of immunomodulator cotreatment and withdrawal on infliximab on trough levels in 223 patients with Crohn's disease." Journal of Crohn's and Colitis (2011).
P. Gevaert, N. Van Bruaene, T. Cattaert, K. Van Steen, T. Van Zele, F. Acke, N. De Ruyck et al. "Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis." Journal of Allergy and Clinical Immunology 128, no. 5 (2011): 989-9958.
L. Henckaerts, I. Cleynen, M. Brinar, J. Mahachie John, K. Van Steen, P. Rutgeerts, and S. Vermeire. "Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease." Inflammatory Bowel Diseases 17, no. 6 (2011): 1392-1397.
M. Joossens, G. Huys, K. Van Steen, M. Cnockaert, S. Vermeire, P. Rutgeerts, K. Verbeke, P. Vandamme, and V. De Preter. "High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake." FEMS Microbiology Ecology 75, no. 2 (2011): 343-9.
M. Jurgens, J. Mahachie John, I. Cleynen, F. Schnitzler, H. Fidder, W. van Moerkercke, V. Ballet et al. "Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease." Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 9, no. 5 (2011): 421-71.
J. Mahachie John, F. Van Lishout, and K. Van Steen. "Model-Based Multifactor Dimensionality Reduction to detect epistasis for quantitative traits in the presence of error-free and noisy data." European Journal of Human Genetics 19 (2011): 696-703.
L. Marquez, C. Shen, I. Cleynen, G. De Hertogh, K. Van Steen, K. Machiels, C. Perrier et al. "Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis." Gut 61, no. 4 (2011): 528-534.
L. N. Moens, P. De Rijk, J. Reumers, M. J. A. Van den Bossche, W. Glassee, S. De Zutter, A.-S. Lenaerts et al. "Sequencing of DISC1 pathway genes reveals increased burden of rare missense variants in schizophrenia patients from a northern Swedish population." PLoS ONE 6, no. 8 (2011): 23450.
T. Ochsenkühn, A. Steinborn, F. Beigel, S. Breiteneicher, J. Mahachie John, K. Van Steen, F. Schnitzler et al. "Rate of Malignancies and Infections in a Large Single Center Cohort of IBD Patients Treated With Thiopurines and Anti-TNF-Antibodies." Journal of Crohn's and Colitis (2011).
F. Schnitzler, H. Fidder, M. Boukerroucha, V. Ballet, M. Noman, G. Van Assche, B. Spitz et al. "Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy." Inflammatory Bowel Diseases 17, no. 9 (2011): 1846-1854.
A. Steinborn, F. Beigel, S. Breiteneicher, K. Van Steen, F. Schnitzler, B. Göke, M. Weidinger, S. Brand, T. Ochsenkühn, and J. Seiderer. "Risk Of Malignancies In A Single Center Cohort Of IBD-Patients Treated with Immunosuppressives and Anti-TNF-antibodies." Journal of Crohn's and Colitis (2011).
A. Steinborn, F. Beigel, S. Breiteneicher, K. Van Steen, F. Schnitzler, B. Göke, M. Weidinger, S. Brand, T. Ochsenkühn, and J. Seiderer. "Risk Of Malignancies In A Single Center Cohort Of IBD-Patients Treated with Immunosuppressives and Anti-TNF-antibodies." American Journal of Gastroenterology (2011).
K. Van Steen. "Perspectives on genome-wide multi-stage family-based association studies." Statistics in Medicine 30, no. 18 (2011): 2201-2221.
K. Van Steen. "Travelling the world of gene-gene interactions." Briefings in Bioinformatics 13, no. 1 (2011): 1-19.
K. Van Steen. "Travelling the world of gene-gene interactions – invited submission to Briefings in Bioinformatics." Briefings in Bioinformatics (2011).
K. Van Steen and K. Sleegers. "A report of the first biennial meeting on Capita Selecta in Complex Disease Analysis (CSCDA2010), Leuven, Belgium, August 25-27, 2010." Annals of Human Genetics 75, no. 4 (2011): 554-7.
N. Vermeulen, K. O. de Beeck, S. Vermeire, K. Van Steen, G. Michiels, V. Ballet, P. Rutgeerts, and X. Bossuyt. "Identification of a novel autoantigen in inflammatory bowel disease by protein microarray." Inflammatory Bowel Diseases 17, no. 6 (2011): 1291-300.
A. Ziegler, K. Van Steen, and S. Wellek. "Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis." Breast Cancer Research and Treatment 128, no. 1 (2011): 197-201.
I. Arijs, R. Quintens, K. Lemaire, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche et al. "The impact of infliximab therapy on intestinal mucosal gene expression of endothelial cell adhesion molecules in patients with inflammatory bowel disease." Gastroenterology 138, 5 Suppl I (2010): -677.
I. Arijs, R. Quintens, K. Lemaire, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche et al. "Intestinal mucosal expression of matrix metalloproteinase and ADAM genes in patients with inflammatory bowel disease and the impact of infliximab therapy." Gastroenterology 138, no. 5 (2010): 677.
I. Arijs, R. Quintens, K. Lemaire, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche et al. "Intestinal mucosal gene expression of endothelial cell adhesion molecules in patients with inflammatory bowel disease and the impact of infliximab therapy." Journal of Crohn's and Colitis (2010).
I. Arijs, R. Quintens, K. Lemaire, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche et al. "Intestinal mucosal gene expression of endothelial cell adhesion molecules in patients with inflammatory bowel disease before and after first infliximab treatment." Acta Gastro-Enterologica Belgica (2010).
I. Arijs, R. Quintens, L. Van Lommel, K. Van Steen, G. De Hertogh, K. Lemaire, A. Schraenen et al. "Predictive value of epithelial gene expression profiles for response to infliximab in Crohn’s disease." Inflammatory Bowel Diseases 16, no. 12 (2010): 2090-2098.
C. Bachert, N. Zhang, G. Holtappels, L. De Lobel, P. van Cauwenberge, S. Liu, P. Lin, J. Bousquet, and K. Van Steen. "Presence of IL-5 and Ige-antibodies to staphylococcal enterotoxins in nasal polyps is associated with co-morbid asthma." Journal of Allergy and Clinical Immunology 126, no. 5 (2010): 962-968.
C. Breynaert, F. Ferrante, H. Fidder, K. Van Steen, M. Noman, V. Ballet, S. Vermeire, P. Rutgeerts, and G. Van Assche. "Tolerability of shortened infliximab infusion times in patients with inflammatory bowel disease: a single center cohort study." Gut (2010): 174-0398.
M. L. Calle, V. Urrea, and K. Van Steen. "mbmdr: an R package for exploring gene-gene interactions associated with binary or quantitative traits." Bioinformatics 26, no. 17 (2010): 2198-2199.
T. Cattaert, V. Urrea, A. C. Naj, L. De Lobel, V. De Wit, M. Fu, J. Mahachie John et al. "FAM-MDR: A Flexible Family-Based Multifactor Dimensionality Reduction Technique to Detect Epistasis Using Related Individuals." PLoS ONE 5, no. 4 (2010): -.
I. Cleynen, J. Mahachie John, L. Henckaerts, W. Van Moerkercke, P. Rutgeerts, K. Van Steen, and S. Vermeire. "Molecular Reclassification of Crohn’s Disease by cluster analysis of genetic variants." Acta Gastro-Enterologica Belgica (2010).
I. Cleynen, J. Mahachie John, L. Henckaerts, W. Van Moerkercke, P. Rutgeerts, K. Van Steen, and S. Vermeire. "Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants." PLoS ONE 5, no. 9 (2010): 12952.
R. T. Cohen, B. A. Raby, K. Van Steen, A. L. Fuhlbrigge, J. C. Celedón, B. A. Rosner, R. C. Strunk, R. S. Zeiger, and S. T. Weiss. "In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma." Journal of Allergy and Clinical Immunology 126, no. 3 (2010): 491-497.
L. De Lobel, P. Geurts, G. Baele, F. Castro-Giner, M. Kogevinas, and K. Van Steen. "A screening methodology based on Random Forests to improve the detection of gene-gene interactions." European Journal of Human Genetics 18, no. 1127 (2010): 1132.
H. Fidder, K. Van Steen, G. Van Assche, P. Rutgeerts, and S. Vermeire. "Immortal time bias and infliximab-related mortality and malignancy incidence." Gut 59 (2010): 416.
H. Fidder, K. Van Steen, G. Van Assche, P. Rutgeerts, and S. Vermeire. "Reanalysis of death risk in long-term follow-up in infliximab patients versus controls." Gut 59 (2010): 416.
M. Joossens, K. Van Steen, J. Branche, B. Sendid, P. Rutgeerts, F. Vasseur, D. Poulain et al. "Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease." Inflammatory Bowel Diseases 16, no. 1 (2010): 58-67.
M. Jürgens, J. Mahachie John, I. Cleynen, F. Schnitzler, V. Ballet, M. Noman, I. Hoffman et al. "Kinetics of C-Reactive Protein (CRP) following maintenance infliximab treatment in Crohn's disease identifies profiles of patients with better outcome." Gastroenterology 138, 5 (Suppl I) (2010): -686.
M. Jürgens, J. Mahachie John, K. Van Steen, F. Schnitzler, V. Ballet, M. Noman, I. Hoffman, G. Van Assche, P. Rutgeerts, and S. Vermeire. "Kinetics of C-reactive Protein (CRP) Following Maintenance Infliximab Treatment in Crohn’s disease identifies profiles of patients with better outcome." Journal of Crohn's and Colitis (2010).
J. Mahachie John, H. Baurecht, E. Rodriguez, A. Naumann, S. Wagenpfeil, N. Klopp, M. Mempel et al. "Analysis of the high affinity IgE receptor genes reveals epistatic effects of FCER1A variants on eczema risk." Allergy 65, no. 7 (2010): 875-882.
J. Mahachie John, S. Roll, S. Lau, K. C. Lodrup Carlsen, K. H. Carlsen, C. Kuehni, B. Spycher et al. "Longitudinal study of European birth cohorts on pet ownership up to age 10 years as a risk for childhood asthma - a GA²LEN project." European Respiratory Journal. Supplement 36, supplement 54 (2010).
K. Van Steen and G. Molenberghs. "Multicollinearity." In Encyclopedia of Biopharmaceutical Statistics. Edited by Chow. Shein-Chung Chow [edit.], 2010.
I. Arijs, G. De Hertogh, K. Lemaire, R. Quintens, L. Van Lommel, K. Van Steen, P. Leemans et al. "Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment." PLoS ONE 4, no. 11 (2009): 7984.
I. Arijs, K. Lemaire, R. Quintens, L. Van Lommel, C. Perrier, K. Van Steen, G. De Hertogh et al. "The impact of infliximab therapy on intestinal mucosal expression of matrix metalloproteinase and ADAM genes in patients with inflammatory bowel disease." Gut (2009).
I. Arijs, K. Li, G. Toedter, R. Quintens, L. Van Lommel, K. Van Steen, P. Leemans et al. "Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis." Gut 58, no. 12 (2009): 1612-9.
I. Arijs, R. Quintens, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, and P. Rutgeerts. "The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease." Gastroenterology 136 (2009): 1190.
I. Arijs, R. Quintens, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche, S. vermeire, K. Geboes, F. Schuit, and P. Rutgeerts. "The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease." Acta Gastro-Enterologica Belgica (2009).
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, R. Quintens, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, and P. Rutgeerts. "Colonic mucosal expression of barrier genes in patients with inflammatory bowel disease before and after first infliximab treatmen." Acta Gastro-Enterologica Belgica (2009).
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, R. Quintens, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, and P. Rutgeerts. "TECK and MADCAM-1 mucosal expression in active IBD: the effect of infliximab therapy." Gastroenterology 136 (2009): 1180.
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, and P. Rutgeerts. "Colonic mucosal expression of barrier genes in patients with inflammatory bowel disease before and after first infliximab treatment." Journal of Crohn's and Colitis 3, no. 1 (2009): 3.
V. Bogaert, G. Vanbillemont, Y. Taes, D. De Bacquer, E. Deschepper, K. Van Steen, and J. M. Kaufman. "Small effect of the androgen receptor gene GGN repeat polymorphism on serum testosterone levels in healthy men." European Journal of Endocrinology 161, no. 1 (2009): 171-7.
I. Cleynen, J. Mahachie John, L. Henkaerts, Van Moerkercke, P. Rutgeerts, K. Van Steen, and S. Vermeire. "Molecular Reclassification of Crohn’s Disease by cluster analysis of genetic variants." Gut (2009).
I. Cleynen, W. Van Moerkercke, J. Mahachie John, P. Rutgeerts, K. Van Steen, and S. Vermeire. "Cluster analysis of genetic variants enables reclassification of Crohn’s disease at the molecular level." Gut (2009).
L. De Lobel, H. De Meyer, L. Thijs, T. Kouznetsova, J. Staessen, and K. Van Steen. "A Family-Based Association Test to Detect Gene-Gene Interactions in the Presence of Linkage." Genetic Epidemiology 33, no. 8 (2009): 77168.
L. Henckaerts, K. R. Nielsen, R. Steffensen, K. Van Steen, C. Mathieu, A. Giulietti, P. J. Wouters et al. "Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit." Critical Care Medicine 37, no. 1 (2009): 192-2011-3.
L. Henckaerts, K. Van Steen, I. Verstreken, I. Cleynen, A. Franke, S. Schreiber, P. Rutgeerts, and S. Vermeire. "Genetic risk profiling and prediction of disease course in Crohn's disease patients." Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 7, no. 9 (2009): 972-9802.
M. Jürgens, F. Schnitzler, K. Van Steen, J. Mahachie John, V. Ballet, M. Noman, I. Hoffman, G. Van Assche, P. Rutgeerts, and S. Vermeire. "Predictive Value of C-Reactive Protein Level Changes On the Long Term Outcome of Infliximab in Crohn's Disease." Acta Gastro-Enterologica Belgica (2009).
M. Jürgens, F. Schnitzler, K. Van Steen, J. Mahachie John, V. Ballet, M. Noman, I. Hoffman, G. Van Assche, P. Rutgeerts, and S. Vermeire. "Predictive Value of C-Reactive Protein Level Changes On the Long Term Outcome of Infliximab in Crohn's Disease." Gastroenterology 136, no. 5 (2009): 171.
B. A. Raby, K. Van Steen, J. Lasky-Su, K. Tantisira, F. Kaplan, and S. T. Weiss. "Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma." Respiratory Research 10 (2009): 67.
S. Ripatti, T. Becker, H. Bickeboller, A. Dominicus, C. Fischer, K. Humphreys, G. Jonasdottir et al. "GENESTAT: an information portal for design and analysis of genetic association studies." European Journal of Human Genetics 17, no. 4 (2009): 533-6.
F. Schnitzler, H. Fidder, M. Ferrante, M. Noman, I. Arijs, G. Van Assche, I. Hoffman, K. Van Steen, S. Vermeire, and P. Rutgeerts. "Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort." Gut 58, no. 4 (2009): 492-500.
F. Schnitzler, H. Fidder, M. Ferrante, M. Noman, I. Arijs, G. Van Assche, I. Hoffman, K. Van Steen, S. Vermeire, and P. Rutgeerts. "Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease." Inflammatory Bowel Diseases 15, no. 9 (2009): 1295-1301.
G. Vanbillemont, V. Bogaert, D. De Bacquer, B. Lapauw, S. Goemaere, K. Toye, K. Van Steen, Y. Taes, and J. M. Kaufman. "Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men." Clinical Endocrinology 70, no. 2 (2009): 303-310.
I. Arijs, K. Lemaire, R. Quintens, L. Van Lommel, P. Leemans, K. Van Steen, G. De Hertogh et al. "Gene expression of antimicrobial peptides in colonic mucosa of patients with inflammatory bowel disease before and after first infliximab treatment." Gut 57, Suppl II (2008): 102-103.
I. Arijs, R. Quintens, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, and P. Rutgeerts. "Effect of infliximab treatment on colonic mucosal gene expression profiles in patients with inflammatory bowel disease." Gut 57, Suppl II (2008): 39.
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, M. Ferrante, M. Joossens, K. Geboes et al. "Mucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease." Journal of Crohn's and Colitis 2, no. 1 (2008): 64.
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, M. Ferrante, M. Joossens, K. Geboes et al. "Mucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease." Acta Gastro-Enterologica Belgica (2008).
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, M. Ferrante, M. Joossens, K. Geboes et al. "Mucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease." Gastroenterology 134 (2008): 117.
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, R. Quintens, K. Lemaire, M. Joossens et al. "Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after infliximab treatment." Journal of Crohn's and Colitis 2, no. 1 (2008): 60.
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, R. Quintens, K. Lemaire, Joossens et al. "Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after first infliximab treatment." Gastroenterology 134 (2008): 2043.
V. Bogaert, Y. Taes, P. Konings, K. Van Steen, D. De Bacquer, S. Goemaere, H. Zmierczak, P. Crabbe, and J.-M. Kaufman. "Heritability of blood concentrations of sex-steroids in relation to body composition in young adult male siblings." Clinical Endocrinology 69, no. 1 (2008): 129-35.
M. L. Calle, V. Urrea, N. Malats, and K. Van Steen. "Improving strategies for detecting genetic patterns of disease susceptibility in association studies." Statistics in Medicine 27, no. 30 (2008): 6532-6546.
F. Castro-Giner, M. Kogevinas, M. Maechler, R. de Cid, K. Van Steen, M. Imboden, C. Schindler et al. "TNFA-3086 > A in two international population-based cohorts and risk of asthma." European Respiratory Journal 32, no. 2 (2008): 350-361.
L. De Lobel, H. De Meyer, L. Thijs, T. Kouznetsova, J. Staessen, and K. Van Steen. "A Family-based Association Test for Quantitative Traits to Detect Gene-Gene Interactions." Genetic Epidemiology 32, no. 7 (2008): 686-686.
M. Ferrante, S. Vermeire, H. Fidder, F. Schnitzler, M. Noman, G. Van Assche, G. De Hertogh et al. "Long-term outcome after infliximab for refractory ulcerative colitis." Journal of Crohn's and Colitis 2, no. 3 (2008): 219-225.
M. Ferrante, S. Vermeire, F. Schnitzler, M. Noman, G. Van Assche, I. Arijs, M. Joossens et al. "Long-term efficacy of infliximab and colectomy-free survival in outpatients with refractory ulcerative colitis." Journal of Crohn's and Colitis 2, no. 1 (2008): 3.
L. Henckaerts, I. Cleynen, M. Joossens, K. Van Steen, K. Claes, P. Rutgeerts, and S. Vermeire. "Genetic markers and the risk of complicated disease behaviour in Crohn's disease patients." Gastroenterology 134, no. 4 (2008): 349-349.
M. Joossens, V. De Preter, K. Van Steen, N. Vermeulen, G. Huys, K. Verbeke, P. Van Damme, P. Rutgeerts, and S. Vermeire. "Stability of gut microbiota over time in Crohn's disease patients compared to healthy relatives." Gastroenterology 134, no. 4 (2008): 653-653.
M. Joossens, V. De Preter, K. Van Steen, N. Vermeulen, G. Huys, K. Verbeke, P. Vandamme, and P. Rutgeerts. "Stability Of Gut Microbiota Over Time In Crohn's Disease Patients Compared To Healthy Relatives." Journal of Crohn's and Colitis 2, no. 1 (2008): 94.
M. Joossens, V. De Preter, K. Van Steen, N. Vermeulen, G. Huys, K. Verbeke, P. Vandamme, P. Rutgeerts, and S. Vermeire. "Long term stability of gut microbiota in Crohn’s disease patients compared to healthy relatives." Acta Gastro-Enterologica Belgica 71 (2008): 73.
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, F. Schuit, K. Geboes, G. Van Assche, S. Vermeire, and P. J. Rutgeerts. "Gene expression profiling to predict the response of infliximab in patients with UC." Journal of Crohn's and Colitis 1, no. 1 (2007): 34.
I. Arijs, L. Van Lommel, K. Van Steen, G. De Hertogh, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, and P. Rutgeerts. "Mucosal gene expression profiling to predict response to infliximab in patients with ulcerative colitis." Gut 56, Suppl III (2007): 19.
I. Arijs, L. Van lommel, K. Van Steen, G. De hertogh, F. Schuit, K. Geboes, G. Van assche, S. Vermeire, and P. J. Rutgeerts. "Gene expression profiling to predict the response of infliximab in patients with UC." Gastroenterology 132, no. 4 (2007): 174-174.
F. Efficace, A. Bottomley, C. Coens, K. Van Steen, T. Conroy, P. Schoeffski, H. Schmoll, E. Van Cutsem, and C.-H. Koehne. "Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? (vol 42, pg 42, 2006)." European Journal of Cancer 43, no. 3 (2007): 633-633.
M. Ferrante, L. Henckaerts, M. Joossens, M. Pierik, S. Joossens, N. Dotan, G. Norman et al. "New serological markers in inflammatory bowel disease are associated with complicated disease behavior." Gut 56, no. 10 (2007): 1394-1403.
L. Henckaerts, I. Verstreken, K. Van Steen, R. Vlietinck, P. Rutgeerts, and S. Vermeire. "Genetic markers and the risk of complicated disease behaviour in Crohn's disease patients." Gastroenterology 132, no. 4 (2007): 17-18.
L. Henckaerts, I. Verstreken, K. Van Steen, R. Vlietinck, P. Rutgeerts, and S. Vermeire. "Genetic markers and the risk of complicated disease behaviour in Crohn’s disease patients." Gut (2007).
L. Henckaerts, I. Verstreken, K. Van Steen, R. Vlietinck, P. Rutgeerts, and S. Vermeire. "Genetic markers and the risk of complicated disease behaviour in Crohn's disease patients." Journal of Crohn's and Colitis 1, no. 1 (2007): 41-42.
M. Joossens, V. De Preter, T. Vanhoutte, K. Van Steen, G. Huys, K. Verbeke, P. Vandamme, P. Rutgeerts, and S. Vermeire. "Faecal bacterial molecular profiles of Crohn’s disease patients differ from their healthy relatives and matched healthy controls." Gut 56, Suppl III (2007): 5.
M. Joossens, T. Vanhoutte, V. De Preter, K. Van Steen, L. Henckaerts, I. Arijs, G. Huys et al. "Faecal bacterial dgge profiles of Crohn's disease patients are different from those of their healthy first degree relatives and matched healthy controls." Gastroenterology 132, no. 4 (2007): 704-704.
M. Joossens, T. Vanhoutte, V. De Preter, K. Van Steen, L. Henckaerts, G. Huys, K. Verbeke, P. Vandamme, P. Rutgeerts, and S. Vermeire. "Faecal bacterial DGGE profiles of Crohn’s disease patients are different from those of their healthy first degree relatives and matched healthy controls." Acta Gastro-Enterologica Belgica (2007).
M. Joossens, T. Vanhoutte, V. De preter, K. Van Steen, L. Henckaerts, I. Arijs, G. Huys et al. "Faecal bacterial dgge profiles of Crohn's disease patients are different from those of their healthy first degree relatives and matched healthy controls." Journal of Crohn's and Colitis 1, no. 1 (2007): 55.
G. Molenberghs, C. Beunkens, H. Thijs, I. Jansen, G. Verbeke, M. Kenward, and K. Van Steen. "Analysis of incomplete data." In SAS System for Clinical Trials II. 2007.
M. Pierik, K. Van Steen, M. Joossens, P. J. Rutgeerts, and S. Vermeire. "Mixed IBD families: A distinct entity within IBD." Gastroenterology 132, no. 4 (2007): 450-450.
S. Roll, T. Keil, E. Eller, C. Bindslev-Jensen, U. Kraemer, C. Chen, A. von Berg et al. "Pet ownership in eight European birth cohorts - results of a GA(2)LEN initiative." Allergy 62 (2007): 67-67.
K. Van Steen, N. M. Laird, P. Markel, and G. Molenberghs. "Approaches to handling incomplete data in family-based association testing." Annals of Human Genetics 71, Pt 2 (2007): 141-51.
F. Efficace, A. Bottomley, C. Coens, K. Van Steen, T. Conroy, P. Schoffski, H. Schmoll, E. Van Cutsem, and C. H. Kohne. "Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?" European Journal of Cancer 42, no. 1 (2006): 42-9.
M. Pierik, S. Joossens, K. Van Steen, N. Van Schuerbeek, R. Vlietinck, P. Rutgeerts, and S. Vermeire. "Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases." Inflammatory Bowel Diseases 12, no. 1 (2006): 1-8.
B. A. Raby, E. S. Hwang, K. Van Steen, K. Tantisira, S. Peng, A. Litonjua, R. Lazarus et al. "T-bet polymorphisms are associated with asthma and airway hyperresponsiveness." American Journal of Respiratory and Critical Care Medicine 173, no. 1 (2006): 64-70.
B. A. Raby, K. Van Steen, R. Lazarus, J. C. Celedon, E. K. Silverman, and S. T. Weiss. "Eotaxin polymorphisms and serum total IgE levels in children with asthma." Journal of Allergy and Clinical Immunology 117, no. 2 (2006): 298-305.
A. Bottomley, F. Efficace, R. Stuppe, K. Van Steen, C. Coens, D. Osoba, M. van Den Bent et al. "A bootstrap model averaging technique to investigate the prognostic value for survival of quality of life information." Quality of Life Research 14, no. 9 (2005): 21361022.
A. Bottomley, E. Smit, F. Efficace, E. Schramel, H. J. Smit, R. Gaafar, B. Biesma et al. "Non-small cell lung cancer and health-related quality of life (HRQOL): Is baseline HRQOL of prognostic value for survival?" Quality of Life Research 14, no. 9 (2005): 20501013.
A. Bottomley, M. Taphoorn, C. Coens, D. Osoba, K. Van Steen, F. Efficace, M. van Den Bent, B. Baumert, and W. Mason. "Predicting survival using health related quality of life scores in glioblastoma cancers: Findings from an international phase III randomised controlled trial." Journal of Clinical Oncology 23, 16S (2005): 9601.
F. Efficace, A. Bottomley, C. Coens, K. Van Steen, T. Conroy, and C. H. Köhne. "The value of patient-reported symptoms as prognostic factors for survival in advanced colorectal cancer." Journal of Clinical Oncology 23, 16S (2005): 267.
F. Efficace, A. Bottomley, C. Coens, K. Van Steen, T. Conroy, P. Schöffski, H. Schmoll, E. Van Cutsem, and C. H. Köhne. "The prognostic value of health related quality of life in colorectal cancer patients: A multivariate analysis using a bootstrap model-averaging approach." Quality of Life Research 14, no. 9 (2005): 21371030.
N. M. Laird, P. Kraft, C. Lange, and K. Van Steen. "Testing for association in genetic studies." In Respiratory Genetics. Edward Arnold, 2005. 27-46.
M. B. McQueen, B. Devlin, S. V. Faraone, V. L. Nimgaonkar, P. Sklar, J. W. Smoller, R. Abou Jamra et al. "Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q." American Journal of Human Genetics 77, no. 4 (2005): 582-95.
M. B. McQueen, A. Murphy, P. Kraft, J. Su, R. Lazarus, N. M. Laird, C. Lange, and K. Van Steen. "Comparison of linkage and association strategies for quantitative traits using the COGA dataset." BMC Genetics 29, Suppl I (2005): 1-9.
M. B. McQueen, A. Murphy, P. Kraft, J. Su, R. Lazarus, N. M. Laird, C. Lange, and K. Van Steen. "Comparison of linkage and association strategies for quantitative traits using the COGA dataset." BMC Genetics 6 Suppl 1 (2005): 96.
B. Moerkerke, E. Goetghebeur, K. Van Steen, S. Vanbelle, and V. Cocquyt. "Permutation based methods for comparing quality of life between observed treatments." Statistics in Medicine 24, no. 24 (2005): 4055-66.
G. Molenberghs, C. Beunkens, I. Jansen, H. Thijs, G. Verbeke, M. Kenward, and K. Van Steen. "Analysis of incomplete data." In 'SAS System for Clinical Trials II. 2005.
A. Murphy, M. B. McGueen, J. Su, P. Kraft, R. Lazarus, N. M. Laird, C. Lange, and K. Van Steen. "Genomic screening in family-based association testing." BMC Genetics 6 (2005): -.
A. Murphy, M. B. McGueen, J. Su, P. Kraft, R. Lazarus, N. M. Laird, C. Lange, and K. Van Steen. "Genomic screening in family-based association testing." BMC Genetics 29 (2005).
B. A. Raby, K. Van Steen, J. C. Celedon, A. A. Litonjua, C. Lange, and S. T. Weiss. "Paternal history of asthma and airway responsiveness in children with asthma." American Journal of Respiratory and Critical Care Medicine 172, no. 5 (2005): 552-8.
M. Van Ranst, M. Joossens, S. Joossens, K. Van Steen, M. Pierik, S. Vermeire, and P. Rutgeerts. "Crohn's disease and month of birth." Inflammatory Bowel Diseases 11, no. 6 (2005): 597-9.
K. Van Steen and C. Lange. "PBAT: a comprehensive software package for genome-wide association analysis of complex family-based studies." Human Genomics 2, no. 1 (2005): 67-9.
K. Van Steen, M. B. McQueen, A. Herbert, B. Raby, H. Lyon, D. L. DeMeo, A. Murphy et al. "Genomic screening and replication using the same data set in family-based association testing." Nature Genetics 37, no. 7 (2005): 683-691.
K. Van Steen, M. B. McQueen, A. Herbert, C. Rosenow, E. K. Silverman, N. M. Laird, S. T. Weiss, and C. Lange. "Genomic screening in family-based association testing and the multiple testing problem." Nature Genetics 28 (2005): 164.
K. Van Steen, B. Raby, G. Molenberghs, H. Thijs, De Wit, and M. Peeters. "An equivalence test for comparing DNA sequences." Pharmaceutical Statistics 4, no. 3 (2005): 203-214.
F. Efficace, L. Biganzoli, M. Piccart, C. Coens, K. Van Steen, T. Cufer, R. E. Coleman et al. "Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer." European Journal of Cancer 40, no. 7 (2004): 1021-1030.
F. Efficace, P. Therasse, M. J. Piccart, C. Coens, K. Van Steen, M. Welnicka-Jaskiewicz, T. Cufer et al. "Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: An international multicenter study." Journal of Clinical Oncology 22, no. 16 (2004): 3381-3388.
N. Esters, M. Pierik, K. Van Steen, S. Vermeire, G. Claessens, S. Joossens, R. Vlietinck, and P. Rutgeerts. "Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease." American Journal of Gastroenterology 99, no. 2 (2004): 299-305.
D. Franchimont, S. Vermeire, H. El Housni, M. Pierik, K. Van Steen, T. Gustot, E. Quertinmont et al. "Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis." Gut 53, no. 7 (2004): 987-992.
S. Joossens, S. Vermeire, K. Van Steen, G. Godefridis, G. Claessens, M. Pierik, R. Hietinck, R. Aerts, P. Rutgeerts, and X. Bossuyt. "Pancreatic autoantibodies in inflammatory bowel disease." Inflammatory Bowel Diseases 10, no. 6 (2004): 771-777.
S. Joossens, M. Daperno, Z. Shums, K. Van Steen, J. A. Goeken, C. Trapani, G. L. Norman et al. "Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis." Clinical Chemistry 50, no. 8 (2004): 1422-5.
C. Lange, K. Van Steen, T. Andrew, H. Lyon, D. L. Demeo, B. Raby, A. Murphy et al. "A family-based association test for repeatedly measured quantitative traits adjusting for unknown environmental and/or polygenic effects." Statistical Applications in Genetics and Molecular Biology 3, no. 1 (2004): 17.
A. Murphy, K. Van Steen, and C. Lange. "On missing phenotype data in multivariate family based association tests: FBAT-GEE-IMP and imputation strategies based on the EM-algorithm, the DA-algorithm and the conditional mean model." Far East Journal of Theoretical Statistics 13, no. 2 (2004): 175-188.
M. Pierik, S. Vermeire, K. Van Steen, S. Joossens, G. Claessens, R. Vlietinck, and P. Rutgeerts. "Tumour necrosis factor- receptor 1 and 2 polymorhpisms in inflammatory bowel disease and their association with response to infliximab." Alimentary Pharmacology and Therapeutics 20 (2004): 303-310.
K. Van Steen, M. McQueen, A. Herbert, N. M. Laird, B. Raby, H. Lyon, J. Su et al. "Genomic screening in family-based association testing." Genetic Epidemiology 27 (2004): 300142.
K. Van Steen and G. Molenberghs. "Multicollinearity." In Encyclopedia of Biopharmaceutical Statistics. Edited by S.-C. Chow. 2004.
K. Van Steen, N. Tahri, and G. Molenberghs. "Introducing the multivariate dale model in population-based genetic association studies." Biometrical Journal 46, no. 2 (2004): 187-202.
S. Vermeire, P. Rutgeerts, K. Van Steen, S. Joossens, G. Claessens, M. Pierik, M. Peeters, and R. Vlietinck. "Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis." Gut 53, no. 7 (2004): 980-986.
A. Bottomley, R. Thomas, K. Van Steen, H. Flechtner, and A. de Graeff. "Guidelines for the use of epoetin: have quality-of-life benefits been proven?" Journal of Clinical Oncology 21, no. 11 (2003): 22232224-5.
I. Jansen, G. Molenberghs, M. Aerts, H. Thijs, and K. Van Steen. "A local influence approach applied to binary data from a psychiatric study." Biometrics 59, no. 2 (2003): 410-9.
S. Joossens, K. Van Steen, S. V. Vermeire, W. Reinisch, J. F. Colombel, and P. Rutgeerts. "The value of serologic markers in indeterminate colitis: A prospective follow-up study - Reply." Gastroenterology 125, no. 3 (2003): 999-1000.
K. Van Steen and G. Molenberghs. "Multivariate and multidimensional analysis." In Biometrics. Oxford, United Kingdom: Eolss, 2003.
S. Vermeire, N. Esters, M. Pierik, G. Claessens, S. Joossens, R. Vlietinck, K. Van Steen, and P. Rutgeerts. "Transmission of CARD15 (NOD2) variants in families with Crohns disease." Gastroenterology 124, 4 (Suppl I) (2003): 368.
S. Vermeire, M. Noman, G. Van Assche, F. Baert, K. Van Steen, N. Esters, S. Joossens, X. Bossuyt, and P. Rutgeerts. "Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: A prospective cohort study." Gastroenterology 125, no. 1 (2003): 32-39.
A. Bottomley, R. Thomas, K. Van Steen, H. Flechtner, and B. Djulbegovic. "Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?" Lancet Oncology 3, no. 3 (2002): 145-53.
A. Bottomley, R. Thomas, K. Van Steen, H. Flechtner, and B. Djulbegovic. "Erythropoietin improves quality of life--a response." Lancet Oncology 3, no. 9 (2002): 527.
I. Jansen, K. Van Steen, G. Molenberghs, M. De Wit, and M. Peeters. "Using word frequencies for testing equivalence between two DNA sequences." Genetic Epidemiology 23 (2002): 287.
S. Joossens, K. Van Steen, S. V. Vermeire, W. Reinisch, J. F. Colombel, and P. Rutgeerts. "The value of serologic markers in indeterminate colitis: A prospective follow-up study." Gastroenterology 122, no. 5 (2002): 1242-1247.
K. Van Steen, D. Curran, J. Kramer, G. Molenberghs, A. Van Vreckem, A. Bottomley, and R. Sylvester. "Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection." Statistics in Medicine 21, no. 24 (2002): 3865-3884.
K. Van Steen, G. Molenberghs, and N. Tahri. "Merits of the multivariate Dale model in genetic association studies." Genetic Epidemiology 23 (2002): 309.
K. Van Steen, G. Molenberghs, and N. Tahri. "The multivariate Dale model and genetic associations." American Journal of Human Genetics 71 (2002): 577.
H. Thijs, K. Van Steen, G. Molenberghs, M. De Wit, and M. Peeters. "An equivalence test for comparing DNA sequences." American Journal of Human Genetics 69, no. 4 (2001): 1576.
K. Van Steen, D. Curran, and G. Molenberghs. "Sensitivity analysis of longitudinal binary quality of life data with drop-out: an example using the EORTC QLQ-C30." Statistics in Medicine 20, no. 24 (2001): 3901-20.
K. Van Steen, G. Molenberghs, G. Verbeke, and H. Thijs. "A Local Influence Approach to Sensitivity Analysis of Incomplete Longitudinal Ordinal Data." Statistical Modelling 1 (2001): 125-142.
K. Van Steen, N. Tahri, and G. Molenberghs. "Introduction of the multivariate Dale model in genetic association studies." American Journal of Human Genetics 69, no. 4 (2001): 1289.
H. Van Maldeghem and K. Van Steen. "Characterizations by automorphism groups of some rank 3 buildings - II: A half strongly-transitive locally finite triangle building is a Bruhat-Tits building." Geometriae Dedicata 74, no. 2 (1999): 113-133.
H. Van Maldeghem and K. Van Steen. "Characterizations by automorphism groups of some rank 3 buildings - IV: Hyperbolic p-adic Moufang buildings of rank 3." Geometriae Dedicata 75, no. 2 (1999): 115-122.
K. Van Steen. "Characterizations by automorphism groups of some rank 3 buildings, III. Moufang-like conditions." Geometriae Dedicata 74, no. 3 (1999): 225-240.
H. Van Maldeghem and K. Van Steen. "Characterizations by automorphism groups of some rank 3 buildings - I. Some properties of half strongly-transitive triangle buildings." Geometriae Dedicata 73, no. 2 (1998): 119-142.
H. Van Maldeghem and K. Van Steen. "Moufang affine buildings have Moufang spherical buildings at infinity." Glasgow Mathematical Journal 39, Part 3 (1997): 237-241.